Shanghai Rightongene Biotechnology Co., Ltd. (SHSE: 688217)
Health Care · Biotechnology · CN
CN¥24.83
-3.20% today · -12.5% 1Y
Shanghai Rightongene Biotechnology Co., Ltd. (SHSE: 688217) operates in the Biotechnology industry within the Health Care sector. The company is valued at $204.58M.
Over the last twelve months the share price has lost 12.5%, trading between 17.81 and 33.27.
Tweenvest scores Shanghai Rightongene Biotechnology Co., Ltd. across four factors: quality 75/100, value 36/100, growth 0/100. Its strongest factor is quality.
688217 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $204.58M
- Revenue (TTM)
- $23.08M
- P/E
- —
- EPS
- -1.23
- Dividend yield
- —
- Beta (5Y)
- 0.40
- 52-week high
- CN¥33.27
- 52-week low
- CN¥17.81
- Avg volume (3M)
- —
- Shares outstanding
- 55.19M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Guangzhou Innogen Pharmaceutical Group Co., LtdSEHK: 2591 | $209.56M | HK$3.60 | -3.49% |
| HLB Therapeutics Co.,Ltd.KOSDAQ: A115450 | $208.16M | ₩3,175.00 | +28.54% |
| TaiGen Biopharmaceuticals Holdings LimitedTPEX: 4157 | $207.71M | NT$9.33 | +7.86% |
| Genomictree Inc.KOSDAQ: A228760 | $206.67M | ₩11,320.00 | -7.21% |
| Anbio BiotechnologyNasdaqGM: NNNN | $204.53M | $4.66 | -16.04% |
| Entrada Therapeutics, Inc.NasdaqGM: TRDA | $204.44M | $5.67 | +5.39% |
| Exagen Inc.NasdaqGM: XGN | $203.98M | $8.42 | +3.06% |
| Japan Tissue Engineering Co., Ltd.TSE: 7774 | $203.38M | ¥793.00 | -4.80% |
Figures last refreshed Oct 11, 2026.